KRYS
Krystal Biotech Inc
322.30$
-0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.5% | +4.3% | +7.5% | +7.0% | +7.5% | +1.8% | +6.0% | +8.9% | +7.6% | +4.7% | +7.4% | |
| – | +1.0% | +2.4% | +13.4% | +4.5% | +4.0% | +3.3% | +9.7% | +10.0% | +10.7% | -0.5% | +3.9% | |
| – | -4.0% | +0.2% | -3.7% | +8.1% | -7.8% | -10.5% | +14.6% | +11.0% | +26.4% | +1.0% | -14.7% | |
| – | -5.3% | +1.1% | +4.0% | +5.1% | +1.6% | +3.2% | +10.6% | +7.2% | +13.2% | -0.5% | +2.7% | |
| – | +351.3% | +10.5% | +122.2% | -5.8% | +7.7% | -1.4% | +7.9% | +16.3% | -1.7% | -0.3% | +9.2% | |
| – | +32.3% | +58.0% | +10.3% | +52.6% | +42.7% | +13.0% | +3.7% | +21.2% | +7.6% | +5.4% | +6.8% | |
| – | +15.4% | +36.1% | +45.7% | +22.5% | +13.5% | -18.0% | +8.9% | +4.6% | +11.8% | +5.3% | +17.7% | |
| – | +20.0% | +43.8% | +51.0% | +24.6% | +13.9% | -22.1% | +9.3% | +5.0% | +12.8% | +4.7% | +18.2% | |
| – | -1.8% | -3.0% | -4.8% | -5.1% | -5.8% | +11.9% | +18.7% | +5.0% | +4.3% | +1.6% | +0.4% | |
| – | -4.8% | +29.7% | +1.2% | +2.9% | -10.7% | -46.4% | +166.6% | -70.6% | +54.4% | +26.3% | +60.0% | |
| – | +3.0% | +2.6% | +5.0% | +5.6% | +6.8% | +4.0% | +5.7% | +9.3% | +7.2% | +4.7% | +6.5% | |
| – | – | – | – | – | – | – | – | – | – | +231.5% | +68.4% | |
| – | -0.3% | +1.6% | +1.2% | +0.9% | -0.1% | 0.0% | -0.4% | +0.3% | +0.4% | +1.9% | +0.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.